SV

Street Verdict

Analyst Scorecard

A record of what Pankaj Pandey said publicly, with the source. Not advice.

“Bullish on Syngene International with a target price of ₹960 for the next one year. The company is witnessing decent revenue growth and a strong margin profile, with US biotech funding slowly picking up. Increased RFPs and on-site visits from prospective customers, along with the 'China rebalancing' de-risking mechanism among big pharma, are expected to provide incremental opportunities.”

Pankaj Pandey’s track record (trackable calls only): 18 graded calls · 95% CI 39–80%

Syngene InternationalBullishCalled 26 Mar 2025Graded 26 Mar 2026
Verdict:MISS

R4 TARGET_CALL: entered ₹719.55 on 2025-03-27 (next trading session's close); neither target nor stop reached by window end 2026-03-26. Window 365 days — rule H1: the quote states "one year".

Read the original articleSee Pankaj Pandey’s full track record